Evaluation of Phage Therapy for Pulmonary Infection of Mouse by Liquid Aerosol-Exposure Pseudomonas aeruginosa

References

• Cai S, Chen Y, Song D, Kong J, Wu Y, Lu H. Study on the resistance mechanism via outer membrane protein OprD2 and metal beta-lactamase expression in the cell wall of Pseudomonas aeruginosa. Exp Ther Med. 2016;12(5):2869–2872. doi:10.3892/etm.2016.369027882088
   PubMed Web of Science ®Google Scholar
• Reza A, Sutton JM, Rahman KM. Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram-negative (ESKAPEE) bacteria. Antibiotics. 2019;8(4):229. doi:10.3390/antibiotics8040229
   Web of Science ®Google Scholar
• Crivaro V, Di Popolo A, Fau - Caprio A, et al. Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis. 2009;9(1):1–719144106
   PubMed Web of Science ®Google Scholar
• Aghamollaei H, Moghaddam MM, Kooshki H, Heiat M, Mirnejad R, Barzi NS. Detection of Pseudomonas aeruginosa by a triplex polymerase chain reaction assay based on lasI/R and gyrB genes. J Infect Public Health. 2015;8(4):314–322. doi:10.1016/j.jiph.2015.03.00325863575
   PubMed Web of Science ®Google Scholar
• Ruiz-Azcona L, Santibanez M, Gimeno A, et al. Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain. Revista espanola de quimioterapia. 2020;33(3):200–206. doi:10.37201/req/024.202032345004
   PubMed Web of Science ®Google Scholar
• Cheng YL, Lee HC, Yeung CY, Chan WT. Clinical significance in previously healthy children of Pseudomonas aeruginosa in the stool. Pediatr Neonatol. 2009;50(1):13–17. doi:10.1016/S1875-9572(09)60024-319326833
   PubMed Web of Science ®Google Scholar
• Ohara T, Itoh K. Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract. Intern Med. 2003;42(11):1072–1076. doi:10.2169/internalmedicine.42.107214686744
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Arun P. Antibiotic/adjuvant combinations (ceftriaxone + sulbactam + adjuvant disodium edetate) as an alternative empiric therapy for the treatment of nosocomial infections: results of a retrospective study. Indian J Cancer. 2017;54(4):685–690. doi:10.4103/ijc.IJC_364_1730082559
   PubMed Web of Science ®Google Scholar
• Qadir MI, Sajjad S. Phage therapy against streptococcus pneumoniae: modern tool to control pneumonia. Crit Rev Eukaryot Gene Expr. 2017;27(4):289–295. doi:10.1615/CritRevEukaryotGeneExpr.201701952729283323
   PubMed Web of Science ®Google Scholar
• Cao F, Wang X, Wang L, et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Research Support, Non-U.S. Gov’t. Biomed Res Int. 2015;2015:752930. doi:10.1155/2015/75293025879036
   PubMed Web of Science ®Google Scholar
• Santos CS, Silva AR. Current and alternative trends in antibacterial agents used in mammalian semen technology. Anim Reprod. 2020;17(1):e20190111. doi:10.21451/1984-3143-AR2019-011132399069
   PubMed Web of Science ®Google Scholar
• Raimondi MV, Presentato A, Li Petri G, et al. New synthetic nitro-pyrrolomycins as promising antibacterial and anticancer agents. Antibiotics. 2020;9(6):292. doi:10.3390/antibiotics9060292
   Web of Science ®Google Scholar
• Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, et al. Clinical aspects of phage therapy. Adv Virus Res. 2012;83:73–121. doi:10.1016/B978-0-12-394438-2.00003-722748809
   PubMed Web of Science ®Google Scholar
• Abedon ST. Phage therapy: eco-physiological pharmacology. Scientifica. 2014;2014:581639. doi:10.1155/2014/58163925031881
   PubMedGoogle Scholar
• Brix A, Cafora M, Aureli M, Pistocchi A. Animal models to translate phage therapy to human medicine. Int J Mol Sci. 2020;21(10):3715. doi:10.3390/ijms21103715
   PubMed Web of Science ®Google Scholar
• Weber-Dabrowska B, Zimecki M, Mulczyk M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch Immunol Ther Exp. 2000;48(1):31–37.
   Google Scholar
• Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind Phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35–45. doi:10.1016/S1473-3099(18)30482-130292481
   PubMed Web of Science ®Google Scholar
• Fong SA, Drilling A, Morales S, et al. Activity of bacteriophages in removing biofilms of pseudomonas aeruginosa isolates from chronic rhinosinusitis patients. Front Cell Infect Microbiol. 2017;7. doi:10.3389/fcimb.2017.00418
   Web of Science ®Google Scholar
• Khairnar K, Raut MP, Chandekar RH, et al. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish. BMC Vet Res. 2013;9(1):264. doi:10.1186/1746-6148-9-26424369750
   PubMed Web of Science ®Google Scholar
• Jeon J, Yong D. Two novel bacteriophages improve survival in galleria mellonella infection and mouse acute pneumonia models infected with extensively drug-resistant Pseudomonas aeruginosa. Appl Environ Microbiol. 2019;85(9). doi:10.1128/AEM.02900-18
   Web of Science ®Google Scholar
• Yang X, Haque A, Matsuzaki S, Matsumoto T, Nakamura S. The efficacy of phage therapy in a murine model of pseudomonas aeruginosa Pneumonia and sepsis. Front Microbiol. 2021;12:1698. doi:10.3389/fmicb.2021.682255
   Web of Science ®Google Scholar
• Morello E, Saussereau E, Fau - Maura D, et al. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One. 2011;6(2):e16963. doi:10.1371/journal.pone.001696321347240
   PubMed Web of Science ®Google Scholar
• Forti F, Roach DR, Cafora M. et al. Design of a broad-range bacteriophage cocktail that reduces pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemoth. 2018;62(6):e02573–e02617. doi:10.1128/AAC.02573-17
   PubMed Web of Science ®Google Scholar
• Abd El-Aziz AM, Elgaml A, Ali YM. Bacteriophage therapy increases complement-mediated lysis of bacteria and enhances bacterial clearance after acute lung infection with multidrug-resistant Pseudomonas aeruginosa. J Infect Dis. 2019;219(9):1439–1447. doi:10.1093/infdis/jiy67830476337
   PubMed Web of Science ®Google Scholar
• Tuon FF, Graf ME, Merlini A, et al. Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae. Braz J Infect Dis. 2017;21(1):1–6. doi:10.1016/j.bjid.2016.09.00827821248
   PubMed Web of Science ®Google Scholar
• Berendt RF, Magruder RD, Frola FR. Treatment of Klebsiella pneumoniae respiratory tract infection of squirrel monkeys with aerosol administration of kanamycin. Am J Vet Res. 1980;41(9):1492–1494.7004284
   PubMed Web of Science ®Google Scholar
• Moyano AJ, Mas CR, Colque CA, Smania AM. Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: in vitro evaluation of a novel aerosol formulation of silver sulfadiazine. Burns. 2020;46(1):128–135. doi:10.1016/j.burns.2019.07.02731420266
   PubMed Web of Science ®Google Scholar
• Hofstetter C, Flondor M, Hoegl S, et al. Aerosol delivery during mechanical ventilation to the rat. Exp Lung Res. 2004;30(7):635–651. doi:10.1080/0190214049048912615371097
   PubMed Web of Science ®Google Scholar
• Chatmongkolchart S, Schettino GP, Dillman C, Kacmarek RM, Hess DR. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position. Crit Care Med. 2002;30(11):2515–2519. doi:10.1097/00003246-200211000-0001812441763
   PubMed Web of Science ®Google Scholar
• Guillon A, Montharu J, Vecellio L, et al. Pulmonary delivery of dry powders to rats: tolerability limits of an intra-tracheal administration model. Int J Pharm. 2012;434(1–2):481–487. doi:10.1016/j.ijpharm.2012.05.01322609125
   PubMed Web of Science ®Google Scholar
• Hoyle N, Zhvaniya P, Balarjishvili N, et al. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. Res Microbiol. 2018;169(9):540–542. doi:10.1016/j.resmic.2018.05.00129777836
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang K, Jiao N, Chen F. Genome sequences of two novel phages infecting marine roseobacters. Environ Microbiol. 2009;11(8):2055–2064. doi:10.1111/j.1462-2920.2009.01927.x19689706
   PubMed Web of Science ®Google Scholar
• Li E, Zhao J, Ma Y, et al. Characterization of a novel Achromobacter xylosoxidans specific siphoviruse: phiAxp-1. Sci Rep. 2016;6(1). doi:10.1038/srep21943.
   Web of Science ®Google Scholar
• Germida JJ, Casida LE. Ensifer adhaerens predatory activity against other bacteria in soil, as monitored by indirect phage analysis. Appl Environ Microbiol. 1983;45(4):1380–1388. doi:10.1128/aem.45.4.1380-1388.198316346275
   PubMed Web of Science ®Google Scholar
• Latino L, Midoux C, Hauck Y, Vergnaud G, Pourcel C. Pseudolysogeny and sequential mutations build multiresistance to virulent bacteriophages in Pseudomonas aeruginosa. Microbiology. 2016;162(5):748–763. doi:10.1099/mic.0.00026326921273
   PubMed Web of Science ®Google Scholar
• Chen F, Cheng X, Li J, et al. Novel lytic phages protect cells and mice against pseudomonas aeruginosa infection. J Virol. 2021;95(8):e01832. doi:10.1128/JVI.01832-20
   Web of Science ®Google Scholar
• Rittich B, Spanova A, Skalnikova M, Benes MJ. Chromatographic behaviour and purification of linear lambda phage and plasmid DNA molecules on 2-hydroxyethyl methacrylate-ethylene dimethacrylate-based supports. J Chromatogr A. 2003;1009(1–2):207–214. doi:10.1016/s0021-9673(03)00241-313677661
   PubMed Web of Science ®Google Scholar
• Pedersen MK, Andersen AB, Folkvardsen DB, et al. Set-up and validation of mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) analysis of Mycobacterium tuberculosis using BioNumerics software. PLoS One. 2018;13(10):e0205336. doi:10.1371/journal.pone.020533630379832
   PubMed Web of Science ®Google Scholar
• Van Domselaar GH, Stothard P, Shrivastava S, et al. BASys: a web server for automated bacterial genome annotation. Nucleic Acids Res. 2005;33(WebServer issue):W455–9. doi:10.1093/nar/gki59315980511
   PubMed Web of Science ®Google Scholar
• Ackermann HW. Phage Classification and Characterization. Humana Press: 2009.
   Google Scholar
• Eller MR, Vidigal PMP, Salgado RL, et al. UFV-P2 as a member of the Luz24likevirus genus: a new overview on comparative functional genome analyses of the LUZ24-like phages. BMC Genomics. 2014;15:7. doi:10.1186/1471-2164-15-724384011
   PubMed Web of Science ®Google Scholar
• Guo T, Xin Y, Zhang C, Kong J. A cytoplasmic antiholin is embedded in frame with the holin in a lactobacillus fermentum bacteriophage. Appl Environ Microbiol. 2018;84(6). doi:10.1128/AEM.02518-17
   Web of Science ®Google Scholar
• Wagemans J, Delattre AS, Uytterhoeven B, et al. Antibacterial phage ORFans of Pseudomonas aeruginosa phage LUZ24 reveal a novel MvaT inhibiting protein. Front Microbiol. 2015;6. doi:10.3389/fmicb.2015.01242
   PubMed Web of Science ®Google Scholar
• Nanvazadeh F, Khosravi AD, Zolfaghari MR, Parhizgari N. Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR. Burns. 2013;39(7):1409–1413. doi:10.1016/j.burns.2013.03.00823773789
   PubMed Web of Science ®Google Scholar
• Vidal F, Mensa J, Martinez JA, et al. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 1999;18(7):473–477. doi:10.1007/s10096005032610482023
   PubMed Web of Science ®Google Scholar
• Hua Y, Luo T, Yang Y, et al. Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice. Front Microbiol. 2017;8:2659. doi:10.3389/fmicb.2017.0265929375524
   PubMed Web of Science ®Google Scholar
• Kvachadze L, Balarjishvili N, Meskhi T, et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb Biotechnol. 2011;4(5):643–650. doi:10.1111/j.1751-7915.2011.00259.x21481199
   PubMed Web of Science ®Google Scholar
• Cafora M, Deflorian G, Forti F, et al. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model. Sci Rep. 2019;9(1). doi:10.1038/s41598-018-37636-x.
   Web of Science ®Google Scholar